Invention Grant
- Patent Title: Tricyclic compounds
- Patent Title (中): 三环化合物
-
Application No.: US14610119Application Date: 2015-01-30
-
Publication No.: US09365579B2Publication Date: 2016-06-14
- Inventor: Neil Wishart , Maria A. Argiriadi , David J. Calderwood , Anna M. Ericsson , Bryan A. Fiamengo , Kristine E. Frank , Michael M. Friedman , Dawn M. George , Eric R. Goedken , Nathan S. Josephsohn , Biqin C. Li , Michael J. Morytko , Kent D. Stewart , Jeffrey W. Voss , Grier A. Wallace , Lu Wang , Kevin R. Woller
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Agency: McCarter & English, LLP
- Agent Elizabeth A. Hanley; Yu Lu
- Main IPC: C07D487/14
- IPC: C07D487/14 ; C07D498/14 ; C07D513/14
Abstract:
The invention provide a compound of Formula (I) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomer and isomer thereof wherein the variable are defined herein. The compound of the invention are useful for treating immunological and oncological conditions.
Public/Granted literature
- US20150210708A1 NOVEL TRICYCLIC COMPOUNDS Public/Granted day:2015-07-30
Information query
